These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 22966789

  • 1. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Jensen JM, Pedersen EB.
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Pedersen EB.
    Scand J Clin Lab Invest; 2012 Feb; 72(1):78-86. PubMed ID: 22149452
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
    Mose FH, Jensen JM, Therwani S, Mortensen J, Hansen AB, Bech JN, Pedersen EB.
    Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445
    [Abstract] [Full Text] [Related]

  • 6. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
    Al Therwani S, Malmberg MES, Rosenbaek JB, Bech JN, Pedersen EB.
    BMC Nephrol; 2017 Aug 15; 18(1):268. PubMed ID: 28810844
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.
    Starklint J, Bech JN, Pedersen EB.
    Scand J Clin Lab Invest; 2005 Aug 15; 65(3):249-61. PubMed ID: 16095054
    [Abstract] [Full Text] [Related]

  • 8. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
    Mose FH, Larsen T, Jensen JM, Hansen AB, Bech JN, Pedersen EB.
    Scand J Clin Lab Invest; 2014 Jan 15; 74(1):8-19. PubMed ID: 24256611
    [Abstract] [Full Text] [Related]

  • 9. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
    Starklint J, Bech JN, Nyvad O, Jensen P, Pedersen EB.
    Scand J Clin Lab Invest; 2006 Jan 15; 66(1):55-66. PubMed ID: 16464787
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
    Lauridsen TG, Vase H, Bech JN, Nielsen S, Pedersen EB.
    Eur J Endocrinol; 2010 May 15; 162(5):961-9. PubMed ID: 20203161
    [Abstract] [Full Text] [Related]

  • 12. Protein-enriched diet increases water absorption via the aquaporin-2 water channels in healthy humans.
    Lauridsen TG, Vase H, Starklint J, Bech JN, Pedersen EB.
    Nephrol Dial Transplant; 2010 Aug 15; 25(8):2502-10. PubMed ID: 20237060
    [Abstract] [Full Text] [Related]

  • 13. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.
    Mose FH, Jörgensen AN, Vrist MH, Ekelöf NP, Pedersen EB, Bech JN.
    BMC Nephrol; 2019 Jun 03; 20(1):200. PubMed ID: 31159750
    [Abstract] [Full Text] [Related]

  • 14. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
    Graffe CC, Bech JN, Lauridsen TG, Pedersen EB.
    Am J Physiol Renal Physiol; 2012 Apr 15; 302(8):F917-27. PubMed ID: 22262484
    [Abstract] [Full Text] [Related]

  • 15. Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects.
    Al Therwani S, Rosenbæk JB, Mose FH, Bech JN, Pedersen EB.
    BMC Nephrol; 2017 Mar 13; 18(1):86. PubMed ID: 28288570
    [Abstract] [Full Text] [Related]

  • 16. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 17. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study.
    Rosenbaek JB, Al Therwani S, Jensen JM, Mose FH, Wandall-Frostholm C, Pedersen EB, Bech JN.
    Am J Physiol Renal Physiol; 2017 Aug 01; 313(2):F378-F387. PubMed ID: 28490529
    [Abstract] [Full Text] [Related]

  • 18. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
    Graffe CC, Bech JN, Lauridsen TG, Vase H, Pedersen EB.
    BMC Nephrol; 2012 Mar 27; 13():15. PubMed ID: 22452789
    [Abstract] [Full Text] [Related]

  • 19. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls.
    Jensen JM, Mose FH, Kulik AE, Bech JN, Fenton RA, Pedersen EB.
    BMC Nephrol; 2014 Jun 26; 15():101. PubMed ID: 24970686
    [Abstract] [Full Text] [Related]

  • 20. Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
    Paulsen L, Holst LM, Bech JN, Starklint J, Pedersen EB.
    Scand J Clin Lab Invest; 2009 Jun 26; 69(3):323-9. PubMed ID: 19051099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.